Reduction of pheniramine toxicity using activated charcoal

Area of Science:

• Pharmacology
• Toxicology
• Materials Science

Background:

• Pheniramine is an antihistamine commonly used for allergies.
• Activated charcoal is a known adsorbent used in poison treatment.
• The efficacy of activated charcoal specifically for pheniramine warrants investigation.

Purpose of the Study:

• To evaluate the adsorption capacity of Norit Medicinal Activated Charcoal for pheniramine in vitro.
• To determine the in vivo effect of activated charcoal on pheniramine blood levels in a canine model.
• To assess the potential of activated charcoal as a first-aid treatment for pheniramine poisoning.

Main Methods:

• In vitro adsorption experiments using Norit Medicinal Activated Charcoal and pheniramine.
• In vivo study involving pheniramine administration followed by activated charcoal in dogs.
• Measurement of pheniramine blood levels to assess absorption and efficacy.

Main Results:

• Pheniramine demonstrated efficient adsorption by Norit Medicinal Activated Charcoal in vitro.
• Dogs treated with activated charcoal after pheniramine ingestion exhibited significantly lower blood pheniramine concentrations.
• The results suggest a significant reduction in systemic pheniramine levels due to activated charcoal intervention.

Conclusions:

• Norit Medicinal Activated Charcoal effectively adsorbs pheniramine.
• Activated charcoal administration is a viable method for reducing pheniramine absorption in vivo.
• Activated charcoal is recommended for first-aid treatment of pheniramine poisoning.